Citation Impact
Citing Papers
Classification and Grading of Gastritis
1996 Standout
Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: Underlying pathological mechanisms
1995
Vagus-Dependent and Vagus-Independent Mechanisms of Action of the Erythromycin Derivative EM574 and Motilin in Dogs
1996 StandoutNobel
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Descending control of pain
2002 Standout
Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors
1988
Synthesis and Properties of Allenic Natural Products and Pharmaceuticals
2004 Standout
Ondansetron
1991
Comparison of the Motor-Stimulating Action of EM523, an Erythromycin Derivative, and Prostaglandin F2 in Conscious Dogs
1993 StandoutNobel
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
1990
Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
1990
Thymoquinone and its therapeutic potentials
2015 Standout
Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: Probable involvement of EP3 receptors
1992
What Makes Clinical Research Ethical?
2000 Standout
Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and plateletsin vitro
1989
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Identification and distribution of 5-HT3 recognition sites within the human brainstem
1990
Ondansetron: A Selective 5‐HT3Receptor Antagonist and Its Applications in CNS‐Related Disorders
2001
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Exposure of cultured human proximal tubular cells to cadmium, mercury, zinc and bismuth: toxicity and metallothionein induction
1998
Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain Tissue
1989
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
2001 StandoutNobel
[11C]S21007, A PUTATIVE PARTIAL AGONIST FOR 5-HT3 RECEPTORS PET STUDIES. RAT AND PRIMATE IN VIVO BIOLOGICAL EVALUATION.
1997
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Ondansetron: A Serotonin Receptor (5-HT3) Antagonist for Antineoplastic Chemotherapy-Induced Nausea and Vomiting
1991
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
A review of central 5-HT receptors and their function
1999 Standout
Helicobacter pyloriInfection
2002 Standout
Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting
1990
Cisplatin: The first metal based anticancer drug
2019 Standout
Eicosanoids and the gastrointestinal tract
1995
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients
2001
Ranitidine Bismuth Citrate Can Help to Overcome Helicobacter pylori Resistance to Clarithromycin In Vivo
2000
Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis
1993
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Effect of E-type prostaglandins on bradykinin-induced plasma extravasation in the knee joint of the rat
1994
5‐HT3 receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret
1989
Mechanism of gastroprokinetic effect of EM523, an erythromycin derivative, in dogs
1993 StandoutNobel
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
The actions of bismuth in the treatment of Helicobacter pylori infection
1997
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species
1989
Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat
1990
Characterisation of the EP-receptor mediating dilatation and potentiation of inflammation in rabbit skin
1995
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
TGF‐β signaling and the fibrotic response
2004 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Perspective on the Development of Lead‐free Piezoceramics
2009 Standout
High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review
2011 Standout
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacy
2000
Enprostil, a Prostaglandin‐E2 Analogue, Inhibits Interleukin‐8 Production of Human Colonic Epithelial Cell Lines
2000
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Synthesis and antiemetic activity of 1,2,3,9-tetrahydro-9-methyl-3-(4-substituted-piperazin-1-ylmethyl)-4H-carbazol-4-one derivatives
2009
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.
1996 StandoutNobel
International Union of Pharmacology. XIII. Classification of Histamine Receptors
1997
Molecular Design of Prostaglandin Probes in Brain Research: High, Specific Binding to a Novel Prostacyclin Receptor in the Central Nervous System
2000 StandoutNobel
Uncommon heavy metals, metalloids and their plant toxicity: a review
2008 Standout
Cyclooxygenase in biology and disease
1998 Standout
Neuropharmacology of emesis induced by anti-cancer therapy
1988
Gastroprotective and Anti-secretory Effect of Nigella sativa Seed and its Extracts in Indomethacin-treated Rats
2004
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
1994 Standout
The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System
2000 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Inhibition of histamine-stimulated gastric acid secretion by Δ9-tetrahydrocannabinol in rat isolated stomach
1980
? 1- and? 2-adrenoceptor binding and functional response in right and left atria of rat heart
1985
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of R. Stables being referenced
Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].
1979
Mechanism of stimulation of colonic secretion in the rat by the prostanoid enprostil
1988
Thromboxane receptors can modulate gastric acid secretion in the rat
1987
Gastric anti‐secretory, mucosal protective, anti‐pepsin and anti‐Helicobacter properties of ranitidine bismuth citrate
1993
SOME in vitro AND in vivo ACTIONS OF THE NEW HISTAMINE H2‐RECEPTOR ANTAGONIST, RANITIDINE
1981
GR63799X--a novel prostanoid with selectivity for EP3 receptors.
1991
H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat
1981
Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an unsurmountable histamine H2‐receptor blocking drug
1985
THE ROLE OF β1 ‐ AND β2‐ADRENOCEPTORS IN THE INHIBITION OF GASTRIC ACID SECRETION IN THE DOG
1978
Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa
1985
Antiemetic properties of the 5HT3-receptor antagonist, gr38032f
1987
Pharmacological interactions between ranitidine, cimetidine, metiamide and tiotidine at histamine H2-receptor sites in guinea-pig atria
1982